Hartmut van Lengerich Joins Protealis’ Board of Directors
Ghent (Belgium), 4 April 2024 – Protealis, a leading seeds and seed technologies developer for sustainable plant proteins, is pleased to announce the appointment of Hartmut van Lengerich as an independent member of its board of directors, effective April 1st, 2024.
David Buckeridge, Chairman of the Board of Protealis, comments: “Hartmut is a highly accomplished agricultural economist and an esteemed leader in the industry. With over three decades of experience in the seed and crop protection sector, encompassing strategic, commercial, and operational domains, his insights will be invaluable to our board.” Benjamin Laga, CEO of Protealis, continued: “With the recent launch of four new soy varieties and our ongoing development of innovative seed technologies such as microbial coatings, the further transition into a commercial entity is pivotal for us. We eagerly anticipate leveraging Hartmut van Lengerich’s extensive commercial acumen.”
Mr. van Lengerich brings a wealth of knowledge to Protealis, backed by a distinguished 30-year career. He has held leadership positions at Bayer CropScience, including CEO roles for Eastern European Regions and Canada, as well as serving as Senior Vice President for Portfolio and Asset Management at Bayer AG, overseeing over $10 billion in worldwide sales.
Excited about the opportunity, Hartmut van Lengerich adds: “I am honoured to join the board of Protealis, which I see as the disruptive protein seed company because of the integration of both state-of-art seed genetics and microbial solutions, backed by an impressive team. Throughout my career, I have navigated numerous transformations, always with a focus on growth. I believe for protein crops in Europe, the moment to act is now: various technologies to facilitate the transition towards more sustainable, and regenerative agricultural practices have converged at Protealis and at the same time public and political awareness for the necessary continued change in agriculture is growing. This presents a significant opportunity for the company, for the farmers and for consumers in Europe.”
Hartmut van Lengerich is a German national and currently serves as a Senior Advisor at the Boston Consulting Group. Additionally, he holds the position of Chairman of the Board at MoA, an ag technology provider based in Oxford, UK, and serves as Chairman of the Strategic Advisory Board at Aphea.Bio in Ghent, Belgium. He also acts as a Strategic Advisor to OerthBio in North Carolina, USA, a developer of targeted protein degradation processes for crop protection agents.
*** END***
More information:
Renate Degrave
Head of Communications and Marketing Protealis
renate.degrave@protealis.com | +32 471 53 60 64
About Protealis
Protealis develops superior plant protein seeds and seed technologies, optimized for the European soil and climate. Being at the forefront of sustainable agriculture, Protealis aims to empower European farmers with sustainable and resilient alternatives to traditional protein sources by developing legume seed solutions with enhanced crop yield and protein levels, while at the same time minimizing the ecological footprint. By addressing the growing demand for more plant-based protein sources, the company is committed to contribute to more sustainable food systems. Today, Protealis is a commercial-stage company with six early maturity soy varieties on the market and is headquartered in the biotechnology cluster in Ghent, Belgium. More info on www.protealis.com, LinkedIn or facebook.
Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Protealis, email us at info@protealis.com and we will no longer process your details for this purpose. You can also find further details in our privacy statement on www.protealis.com.
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Protealis’ (‘the Company’) or, as appropriate, the Company directors' or managements' current expectations and projections concerning future events such as the Company's results of operations, financial condition, liquidity, performance, prospects, growth, strategies and the industry in which the Company operates. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.